Immunohistochemistry (IHC) Market (By Product: Antibodies [Primary Antibodies, Secondary Antibodies], Equipment [Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others], Reagents [Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, Diluents], Kits; By Application: Diagnostics [Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Nephrological Diseases], Drug Testing; By End-Use: Hospitals and Diagnostic Laboratories, Research Institutes, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Published at : February-2019 | Delivery Format : PDF | Status: Published | Pages : 160


The global Immunohistochemistry (IHC) market size is anticipated to around USD 3.7 billion by 2026, this market is anticipated to grow with 8.5% CAGR during the forecast time period. Also, surge in need for better health related solution and diagnostic service drive the global Immunohistochemistry (IHC) market during the coming years.

Market Dynamics

Immunohistochemistry (IHC), as a pivotal use of monoclonal and polyclonal antibodies comprehends tissue dispersion of an antigen. It is broadly utilized for disease finding as it decides the nearness of tumor antigens and comprehend if the tumor is considerate or dangerous. Rising commonness of constant sicknesses and quickly developing elderly populace are the essential components adding to Immunohistochemistry (IHC) market development.

The quantity of cancer growth patients is on the ascent. This factor is required to cause a flood sought after for successful diagnostics. IHC assumes a crucial job in ailment determination by anticipating forecast of tumors. It is utilized in distinguishing proof of catalysts, tumor silencer qualities, antigens, and tumor cell multiplication, among others.

Market Insights

Noteworthy ascent in healthcare spending and move in spotlight on esteem based medicinal services arrangements can additionally prompt development of the immunohistochemistry showcase over the gauge time frame. As indicated by the Centers of Medicare and Medicaid Services (CMS) projections, the National Health Expenditure is foreseen to ascend at a normal of 5.5% consistently from 2017 to 2026. It is relied upon to stretch around USD 5.7 trillion by 2026. Clinics and care offices are embracing an increasingly explicit and focused on treatment for better results and to build up a move esteem based healthcare conveyance.

Market Segmentation

Market By Product

  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining Systems
    • Tissue Microarrays
    • Tissue Processing Systems
    • Slide Scanners
    • Others
  • Reagents
    • Histological Stains
    • Blocking Sera and Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

Market By Application

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing

Market By End-Use

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

Asia Pacific is evaluated to observe the quickest development over the estimate time frame attributable to rising disposable income, high neglected clinical requirements of patients, rising mindfulness about early finding, and accessibility of successful treatment in rising nations, for example, India and China. Asia Pacific is the most encouraging goal for market players because of expanding instances of different sorts of cancers growths in this region. North America was at the front line of the market, with an offer of about 38.0% in 2018. Governments in the particular region are empowering continuous research exercises on Immunohistochemistry (IHC) by financing them.

Market Participants

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the Immunohistochemistry (IHC) are F. Hoffmann-La Roche AG, Abcam plc, Thermo Fisher Scientific, Inc., Agilent Technologies, PerkinElmer, Inc., Bio SB, Merck KGaA, Bio-Rad Laboratories, Inc., Danaher Corporation, and Cell Signaling Technology, Inc.

Cart Summary